Aptahem AB
APTA | SPGR
Overview
Corporate Details
- ISIN(s):
- SE0022447173 (+2 more)
- LEI:
- 549300IVD1BY4CJMSO40
- Country:
- Sweden
- Address:
- Norra Vallgatan 58, 211 22 Malmö
- Website:
- https://aptahem.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Aptahem AB is a clinical-stage biotechnology company that develops RNA-based pharmaceuticals, known as aptamers, for the treatment of acute, life-threatening conditions. The company's research focuses on illnesses where coagulation, inflammation, and tissue damage are involved. Its lead candidate, Apta-1, is an aptamer currently in clinical development with sepsis as its primary indication. Aptahem aims to address the significant unmet medical need for effective treatments for sepsis and other severe inflammatory diseases, which currently rely only on supportive care. The company's proprietary technology leverages the unique multi-mechanistic profile of aptamers as a potential disruptive treatment.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Aptahem AB.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Automate Your Workflow. Get a real-time feed of all Aptahem AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Aptahem AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
